Back
Alnylam Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
277.35
Seasonality Move:
10.72%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
67.07
Seasonality Move:
13.3%
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $277.43. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $67.07. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $277.43
The current trend is relatively stagnant and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $67.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.2 | Sell |
Relative Strength Index (14 RSI): | 49.43 | Sell |
Chaikin Money Flow: | 435362 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (270.23 - 291.39) | Sell |
Bollinger Bands (100): | (237.21 - 286.27) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.77 | Sell |
Relative Strength Index (14 RSI): | 36.99 | Sell |
Chaikin Money Flow: | 38184 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.11 - 70.53) | Sell |
Bollinger Bands (100): | (70.87 - 88.17) | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 272.5 | Buy |
20-day SMA: | 283.25 | Sell |
50-day SMA: | 273.97 | Buy |
200-day SMA: | 207.84 | Buy |
8-day EMA: | 274.92 | Buy |
20-day EMA: | 277.83 | Sell |
50-day EMA: | 272.73 | Buy |
200-day EMA: | 228.92 | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.42 | Buy |
20-day SMA: | 68.68 | Sell |
50-day SMA: | 73.15 | Sell |
200-day SMA: | 82.32 | Sell |
8-day EMA: | 67.03 | Buy |
20-day EMA: | 68.41 | Sell |
50-day EMA: | 72.52 | Sell |
200-day EMA: | 80.98 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Alnylam Pharmaceuticals Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |